Investor
Ideas #Potcasts, #Cannabis News and #Stocks on the Move; Episode 459 (TSXV: $SUGR.V)
(TSX: $AVCN.TO) (CSE: $THC.C) (CSE: $CHV.C) (CSE: $TTT.C)
Listen to the podcast:
https://www.investorideas.com/Audio/Podcasts/2020/082420-StocksToWatch.mp3
Read this in full
at https://www.investorideas.com/news/2020/cannabis-potcasts/08241SUGR-AVCN-THC-CHV-TTT.asp
Hear Investor ideas cannabis potcast on iTunes
Hear the investor ideas potcast on Spotify
Today’s podcast overview/transcript:
Good
afternoon and welcome to another episode of Investorideas.com
"Potcast" featuring cannabis news, stocks to watch as well as
insights from thought leaders and experts.
In
today’s podcast we look at a few public and private company announcements.
Sugarbud
Craft Growers Corp. (TSXV:
SUGR) announced that it
has received approval from Health Canada for its amended sales license
permitting the sale of dried cannabis products. Sugarbud is now able to
directly sell its portfolio of exceptional craft cannabis products to all
authorized provincial and territorial distributors/retailers as well as
registered medical patients.
"Today's announcement
represents yet another pivotal milestone for Sugarbud as we continue to scale
up our commercial activities and build overall shareholder value for the
Company," stated Sugarbud CEO, John Kondrosky. "Our amended Sales
License now gives us the ability to take direct control of our own sales and
marketing activities and further accelerate and expand the distribution of our
core Craft Cannabis Dried Flower and Pre-Roll products into new target
provinces - such as Alberta and British Columbia," continued Mr.
Kondrosky.
The Company estimates that less than
30% of all active federally approved license holders possess a sales license
permitting the sale of dried cannabis to authorized provincial and territorial
distributors/retailers as well as registered medical patients. "Receipt of our amended Sales License is
significant and was the result of a successful comprehensive inspection
process. It is a testament to our day-to-day operational readiness and
unwavering commitment to compliance as much as it is to the hard work, dedication
and passion that our employees continue to demonstrate each and every
day," concluded Mr. Kondrosky.
Sugarbud products are currently
available in the province of Saskatchewan under the terms and conditions of the
previously announced licensing and distribution agreement with Agro-Greens
Natural Products Ltd.
Avicanna
Inc. (TSX:
AVCN) (OTCQX:
AVCNF), a biopharmaceutical company focused on the
development, manufacturing and commercialization of plant-derived
cannabinoid-based products announced that
through its majority owned subsidiary, Santa Marta Golden Hemp S.A.S., the
company has completed exports of CBG and CBD isolates into the United States,
CBD isolate into Germany and the commencement of a pilot tracking system for
the export of its active pharmaceutical ingredient products in partnership with
TruTrace Technologies Inc. (CSE:
TTT)
(OTCQB:
TTTSF). The Company also announced that the Colombian
Ministry of Justice and Law has granted SMGH a commercial and industrial
cultivation quota for 12,264 THC plants by.
The export and sale of the
commercial lot of isolated CBG into the United States was completed in parallel
with commercial export of isolated CBD into the United States, as well as a
pilot export for R&D purposes of CBD into Germany. The cultivation,
extraction and purification of these cannabinoids including the rare cannabinoid,
CBG, were all completed through Avicanna's vertical integration at SMGH and
validate the company's innovation and leadership in natural rare cannabinoid
production. The products are part of the Aureus™ product portfolio that now
includes feminized seeds and advanced formulations as well as CBD, CBG and THC
API products.
"This is another massive
accomplishment for our team in Colombia as we enter the largest market in the
world for non-psychoactive cannabinoids with our proprietary CBG offering. As
the cannabinoid-derived products sector continues to evolve, our Aureus branded
portfolio continues to advance in order to cater to the needs of our cosmetics
and pharmaceutical partners, which require an innovative, credible,
thoroughly-tested, organic, sustainable and economical source of input
materials. Additionally, with the support of TruTrace, the Aureus products will
be provided with traceability and trackability all the way back to the seed
through a secured blockchain system." - Aras Azadian, Chief Executive
Officer of Avicanna.
The Colombian Ministry of Justice
and Law granted SMGH a supplementary cultivation quota to cultivate 12,264
psychoactive cannabis plants. 11,587 plants will be destined to produce dry
flower which will then be used to manufacture psychoactive derivatives for
commercial production for export. The remaining 677 plants will be utilized for
psychoactive derivatives for the purposes of research and development and pilot
production of Avicanna's RHO Phyto™ branded products in Colombia.
Lucas Nosiglia, President of
Avicanna LATAM commented: "This achievement took years of
characterization, evaluation and planning which will finally allow Avicanna to
produce our THC products and export THC derivatives to our international
partners. As one of the only companies permitted to produce THC commercially
for the global market, we can focus on less competitive and high margin
products."
THC
BioMed Intl Ltd. (CSE:
THC)
announced the
following updates:
THC BioMed announced that it has
received notice from the U.S. Patent and Trademark Office, that it has allowed
the patent application for THC's Clone Shipper Constant Illuminated,
Tamper-Resistant Plant Container. This is a successful end to the patent
application process. The next step will be the Issue Notification Letter to
come from the USPTO, which THC expects to receive approximately 3 weeks prior
to the official issuance date of the patent.
As noted in the title, this
container provides the plant inside it with a constant source of light and
helps plants do very well during shipping. The container is also
tamper-resistant, which is important for shipping plants such as cannabis
clones.
THC has also been focused on product
development and sales for "Cannabis 2.0," with edibles and beverages.
It has submitted the following new products to Health Canada for the 60-day
notice period for new products:
THC BioMed's latest product, THC
Kiss Gummies, are tasty gummy candies containing 2.5 mg of THC each. They will
come with 4 in a package (10 mg.) The cannabis extract used is from the same
proprietary extraction system as that used in THC Kiss beverage shot.
THC is also pleased to announce that
a new product, Kiss Water, has been submitted to Health Canada. THC Kiss Water is a refreshing beverage with a
slight herbal taste. Each 220 ml beverage contains 3 mg of THC.
THC chocolate has been formulated
with the same cannabis extract used is from the same proprietary extraction
system as that used in THC Kiss beverage shot and THC Kiss Gummies. The extract
is designed to be fast acting and uplifting and to provide a realistic and
great-tasting alternative to smoking cannabis.
Canada
House Wellness Group Inc. (CSE:
CHV)
announced
today that its wholly owned subsidiary, Abba Medix
Corp., has received its amended sales
license from Health Canada allowing for the sale of cannabis oil, concentrate,
topical and edible products produced from its facility in Pickering, Ontario.
The Company also announced that Abba
has entered into an agreement with Organic Extraction Technologies and is
currently employing equipment and services sourced from OET to produce
solventless cannabis rosin at its Pickering, Ontario facility.
This license amendment allows the
Company to further expand its existing product offerings to the medical and
recreational consumer markets with internally produced oil, concentrate,
extract, topical and edible products.
Abba is currently generating full-spectrum concentrates and will
continue to work closely with Canada House's wholly owned subsidiary, Canada
House Clinics ("CHC"), to
expand its portfolio of products to best manage the complex physical and psychological
conditions of its medical patient base.
"Receiving our Cannabis 2.0
sales license to allow for the sale of higher margin, internally produced
products represents another key milestone on Canada House's path to
profitability," said Chris Churchill-Smith, Canada House CEO. "Cannabis oil, rosin, and edibles are in
high demand, and we've been developing formulations to address the health and
wellness needs specifically as it relates to our Veteran patient base. This
license amendment will allow Abba to capture an even greater share of the over
$27M per year of medical products purchased by CHC's patients."
"It is a pleasure to work with
Abba's terrific team while implementing our technology in their top-notch
facility," commented Lindsay Labelle, CEO of Organic Extraction
Technologies. "Solventless extraction without chemicals or additives only
works with high quality cannabis. Our solventless products will allow us to
showcase some of the best flower and trim in the industry. We are excited to
bring the great genetics grown by Abba and its partners to market in new
full-spectrum formats."
Investor ideas reminds all
listeners to read our disclaimers and disclosures on the Investorideas.com
website and that this podcast is not an endorsement to buy products or services
or securities. Investors are reminded all investment involves risk and possible
loss of investment.
Learn more about
our cannabis podcasts at https://www.investorideas.com/Audio/Potcasts.asp
Hear Investor ideas cannabis potcast on iTunes
Hear the investor ideas potcast on Spotify
To hear more
Investorideas.com podcasts visit: https://www.investorideas.com/Audio/.
Investorideas.com
podcasts are also available on iTunes,
Spotify, Google Play Music, Stitcher, Spreaker, YouTube via Spreaker, iHeartradio and Tunein.
Potcasts is now a certified
word mark Trademark on the blockchain through Cognate, Inc. CM
Certification-Registration Number: 10468217708
About Investorideas.com - News that
Inspires Big Investing Ideas
Investorideas.com
is a recognized news source publishing third party news, research and original
financial content. Learn about investing in stocks and sector trends with our
news alerts, articles, podcasts and
videos, looking at cannabis, crypto, AI and IoT, mining, sports biotech, water,
renewable energy and more. Investor Idea’s original branded content includes
the following podcasts and columns : Crypto Corner , Play
by Play sports and stock news column, Investor Ideas
Potcasts Cannabis News and Stocks on the Move podcast and
column, Cleantech
and Climate Change , Exploring
Mining the AI
Eye .
Disclaimer/Disclosure: Investorideas.com is a
digital publisher of third party sourced news, articles and equity research as
well as creates original content, including video, interviews and articles.
Original content created by investorideas is protected by copyright laws other
than syndication rights. Our site does not make recommendations for purchases
or sale of stocks, services or products. Nothing on our sites should be
construed as an offer or solicitation to buy or sell products or securities.
All investing involves risk and possible losses. This site is currently
compensated for news publication and distribution, social media and marketing,
content creation and more. Disclosure is posted for each compensated news
release, content published /created if required but otherwise the news was not
compensated for and was published for the sole interest of our readers and
followers. Contact management and IR of each company directly regarding
specific questions. More disclaimer info: https://www.investorideas.com/About/Disclaimer.asp Learn more about publishing your news release and our other
news services on the Investorideas.com newswire https://www.investorideas.com/News-Upload/ and tickertagstocknews.com
Global investors must adhere to regulations
of each country. Please read Investorideas.com privacy policy:
https://www.investorideas.com/About/Private_Policy.asp
Investor Ideas does not condone the use of
cannabis except where permissible by law. Our site does not possess,
distribute, or sell cannabis products.
Follow us on Twitter https://twitter.com/Investorideas
Follow
us on Facebook https://www.facebook.com/Investorideas
Follow
us on YouTube https://www.youtube.com/c/Investorideas
Download
our Mobile App for
iPhone and Android
Join
our Investor Club https://www.investorideas.com/membership/
Contact Investorideas.com
800
665 0411
Get more Cannabis Stock Investor Ideas – news,
articles, podcasts and
stock directory
No comments:
Post a Comment